Biocon Ltd. News, Corporate filings and Earnings/Conference Calls

Keep track of all breaking news and updates on Biocon Ltd. from all sources in a single place.

Biocon Ltd.

04 Jul 2025, 02:26PM

380.05

1.50%

Company Update

Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Newspaper Publication

BSE India

Newspaper Publication

pdf

Biocon Ltd.

03 Jul 2025, 02:19PM

380.05

1.50%

Karnataka CM's remark on Covid vaccines 'factually incorrect': Biocon chief

Business Standard

Biocon founder Kiran Mazumdar-Shaw on Thursday opposed Karnataka Chief Minister Siddaramaiah's remarks linking covid-19 vaccines with a spate of heart attack deaths in the state's Hassan district, saying such claims are "'factually incorrect" and "misleading". Siddaramaiah has suggested that the recent heart attack deaths in Hassan district may be linked to the vaccination drive. He had also claimed the vaccines were 'hastily' approved. In a social media post, Shaw said "covid-19 vaccines developed in India were approved under the Emergency Use Authorisation framework, following rigorous protocols aligned with global standards for safety and efficacy. To suggest that these vaccines were 'hastily' approved is factually incorrect and contributes to public misinformation." "These vaccines have saved millions of lives and, like all vaccines, may cause side effects in a very small number of individuals. It is important to acknowledge the science and data-driven processes behind their...

Biocon Ltd. is trading above all available SMAs

Biocon Ltd.

03 Jul 2025, 08:18AM

380.05

1.50%

Company Update

Biocon Ltd - 532523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

BSE India

Press Release

pdf

Biocon Ltd.

02 Jul 2025

380.05

1.50%

Biocon climbs 3% on plans to file approvals for generic weight-loss drug

Business Standard

Biocon share price gained 2.5 per cent after reports suggested that the company is planning to file for generic versions of Novo Nordisk A/S's Ozempic and Wegovy